Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia

Mohamed L. Sorror(University of Washington Medical Center), Elihu H. Estey(University of Washington), Esteban Peña(University of Utah), Andrew M. Brunner(Harvard University), Amir T. Fathi(University of Southern California), Selina M. Luger(University of Pennsylvania), Jennifer E. Nyland(Penn State Milton S. Hershey Medical Center), Lynn Onstad(Fred Hutch Cancer Center), Aaron T. Gerds(Cleveland Clinic), Jeannine S. McCune(City of Hope), Stephanie J. Lee(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Pankit Vachhani(University of Alabama at Birmingham), Eunice S. Wang(Roswell Park Comprehensive Cancer Center), Mitchell Garrison(Wenatchee Valley Hospital & Clinics), Maria R. Baer(University of Maryland, Baltimore), Pamela S. Becker(City Of Hope National Medical Center), Jamie Koprivnikar(Hackensack University Medical Center), Mikkael A. Sekeres(University of Miami), Frederick R. Appelbaum(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), David A. Rizzieri(Duke University), Wendy M. Leisenring(The University of Texas MD Anderson Cancer Center), Barry E. Storer(City Of Hope National Medical Center), Kehinde Adekola(Northwestern Memorial Hospital), Kiarash Kojouri(Skagit Valley Hospital), Tanya M. Wildes(University of Nebraska Medical Center), Brenda M. Sandmaier(University of Washington), Sudipto Mukherjee(Cleveland Clinic), Paul J. Shami(University of Utah), Bruno C. Medeiros(Stanford Medicine), Julie Smith(University of Strathclyde), Mahmoud Elsawy(Dalhousie University)
Blood
April 28, 2021
Cited by 46


Related Papers